Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Accured Expenses (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Change in Accured Expenses readings, the most recent being $778000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 83.96% to $778000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.4 million, a 69.47% increase, with the full-year FY2025 number at -$2.4 million, up 69.47% from a year prior.
  • Change in Accured Expenses hit $778000.0 in Q4 2025 for Treace Medical Concepts, down from $2.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $9.5 million in Q4 2023 to a low of -$6.9 million in Q1 2024.
  • Median Change in Accured Expenses over the past 5 years was $817500.0 (2025), compared with a mean of $216850.0.
  • Biggest five-year swings in Change in Accured Expenses: surged 783.77% in 2022 and later plummeted 675.66% in 2024.
  • Treace Medical Concepts' Change in Accured Expenses stood at -$737000.0 in 2021, then soared by 644.5% to $4.0 million in 2022, then skyrocketed by 136.28% to $9.5 million in 2023, then tumbled by 48.85% to $4.8 million in 2024, then plummeted by 83.96% to $778000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were $778000.0 (Q4 2025), $2.1 million (Q3 2025), and $857000.0 (Q2 2025) per Business Quant data.